Literature DB >> 3800356

Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea.

V H San Joaquin, R K Scribner, D A Pickett, D F Welch.   

Abstract

In vitro susceptibility to 17 antimicrobial agents was determined for Aeromonas caviae, A. hydrophila, and A. sobria isolated from feces of patients with diarrhea. The three Aeromonas species shared a similar susceptibility pattern, except to cephalothin. Of the oral antimicrobial agents, the quinolones, followed by chloramphenicol, were most active; trimethoprim-sulfamethoxazole and tetracycline had good but variable activity.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3800356      PMCID： PMC176537          DOI： 10.1128/AAC.30.5.794

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  The clinical significance of stool isolates of aeromonas.

Authors:  L B Travis; J A Washington
Journal:  Am J Clin Pathol       Date:  1986-03       Impact factor: 2.493

2.  In-vitro susceptibility of Aeromonas app. to antimicrobial agents.

Authors:  C J Richardson; J O Robinson; L B Wagener; V Burke
Journal:  J Antimicrob Chemother       Date:  1982-04       Impact factor: 5.790

3.  In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.

Authors:  R J Fass; J Barnishan
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

4.  In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.

Authors:  V Fainstein; S Weaver; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  Cephalothin susceptibility as a potential marker for the Aeromonas sobria group.

Authors:  J M Janda; M R Motyl
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

6.  Aeromonas-associated gastroenteritis.

Authors:  M Gracey; V Burke; J Robinson
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

7.  The microbiology of childhood gastroenteritis: Aeromonas species and other infective agents.

Authors:  V Burke; M Gracey; J Robinson; D Peck; J Beaman; C Bundell
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

8.  Clinical and microbiological features of Aeromonas hydrophila-associated diarrhea.

Authors:  W A Agger; J D McCormick; M J Gurwith
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

9.  Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides.

Authors:  J F Reinhardt; W L George
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.

Authors:  M R Motyl; G McKinley; J M Janda
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191
View more
  12 in total

1.  In vitro activities of Ro 40-6890 against 164 predominantly intestinal members of the families Enterobacteriaceae and Vibrionaceae.

Authors:  P Hohl; J Zollinger-Iten; A von Graevenitz
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  A 5-year study of the bacterial pathogens associated with acute diarrhoea on the island of Crete, Greece, and their resistance to antibiotics.

Authors:  S Maraki; A Georgiladakis; Y Tselentis; G Samonis
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  Phenotypic and genotypic characterization of tetracycline- and oxytetracycline-resistant Aeromonas hydrophila from cultured channel catfish (Ictalurus punctatus) and their environments.

Authors:  A DePaola; P A Flynn; R M McPhearson; S B Levy
Journal:  Appl Environ Microbiol       Date:  1988-07       Impact factor: 4.792

Review 4.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

5.  Antimicrobial susceptibility patterns of Aeromonas jandaei, A. schubertii, A. trota, and A. veronii biotype veronii.

Authors:  T L Overman; J M Janda
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  beta-Lactam resistance of motile Aeromonas isolates from clinical and environmental sources.

Authors:  K Morita; N Watanabe; S Kurata; M Kanamori
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

7.  Seasonal incidence of and antibiotic resistance among Aeromonas species isolated from domestic wastewater before and after treatment in stabilization ponds.

Authors:  L Hassani; B Imziln; A Boussaid; M J Gauthier
Journal:  Microb Ecol       Date:  1992-05       Impact factor: 4.552

Review 8.  Use of quinolones in the treatment of gastrointestinal infections.

Authors:  H L DuPont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

9.  Purification and characterization of inducible beta-lactamases in Aeromonas spp.

Authors:  J P Iaconis; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

10.  Antimicrobial susceptibility of sixty human fecal isolates of Aeromonas species.

Authors:  E J Kuijper; M F Peeters; B S Schoenmakers; H C Zanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.